Dr. Sarkar received her Ph.D. from Purdue University on Biological Engineering. As a postdoctoral fellow at NCI-NIH with Dr. Esta Sterneck and at M.D. Anderson with Dr. Sendurai Mani, Dr. Sarkar gained extensive experience working with breast cancer cell lines as well as in vivo xenograft models. She has published her work in numerous journals such as PNAS, oncogene, MCB, Cancer Research etc. At Texas A & M, Department of Biology, Dr. Sarkar’s lab is focusing on the role of energy restriction on metastatic tumor growth and also investigating the role of metabolites in cancer progression and metastasis.
Current Research interst of Dr. Tapasree Roy Sarkar is in An aberrant activation of the biological process, termed epithelial-mesenchymal transition (EMT) plays an important role for the acquisition of malignant phenotypes as well as cancer stem cell(CSC) properties by epithelial cancer cells. EMT facilitates the metastatic dissemination which is the major cause of cancer related mortality. The main focus of her work is to identify the molecular mechanisms that induces EMT, and to develop novel therapeutic strategies for preventing and treating metastasis.